Bod Australia Ltd on Feb. 5 said it had been granted authorization to import cannabidiol powder from Linnea Natural Pharma Solutions.
The company was given permission by Australia's Office of Drug Control and will receive the shipment in mid-February.
Bod will incorporate the CBD powder into its sublingual wafer, currently under development through its partner iX Biopharma. This will take about six to eight weeks.
Bod is awaiting approval from the country's Department of Health to import Linnea's CBD oil products. Pending approval, Bod will make it available and generate revenue through a special access scheme category B, the release said.
